These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3203713)

  • 1. Effect of methyldopa on prolactin serum concentration. Comparison between normal and sustained-release formulations.
    Baldini M; Cornelli U; Molinari M; Cantalamessa L
    Eur J Clin Pharmacol; 1988; 34(5):513-5. PubMed ID: 3203713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methyldopa on prolactin and growth hormone.
    Steiner J; Cassar J; Mashiter K; Dawes I; Fraser TR; Breckenridge A
    Br Med J; 1976 May; 1(6019):1186-8. PubMed ID: 1268617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bromocriptine in methyldopa treated hypertension.
    Lewis MJ; Henderson AH
    Br J Clin Pharmacol; 1980 Jan; 9(1):57-60. PubMed ID: 6986893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.
    Routledge PA; Zrinzo LV; Rao JG; Walden RJ; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Mar; 11(3):159-62. PubMed ID: 323023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methyldopa in fifty hypertensive patients.
    Horwitz D; Pettinger WA; Orvis H; Thomas RE; Sjoerdsma A
    Clin Pharmacol Ther; 1967; 8(2):224-34. PubMed ID: 6021583
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive efficacy of a single bedtime dose of methyldopa.
    Wright JM; McLeod PJ; McCullough W
    Clin Pharmacol Ther; 1976 Dec; 20(6):733-7. PubMed ID: 791564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin and blood pressure during treatment with methyldopa.
    Weidmann P; Hirsch D; Maxwell MH; Okun R; Schroth P
    Am J Cardiol; 1974 Nov; 34(6):671-6. PubMed ID: 4422018
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
    Putzeys MR; Hoobler SW
    Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
    [No Abstract]   [Full Text] [Related]  

  • 15. Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension.
    Verhiest W; Croonenberghs J; Devos P; Fagard R; Amery A
    Acta Cardiol; 1974; 29(3):217-33. PubMed ID: 4601854
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of methyldopa. Plasma levels following single intravenous, oral and multiple oral dosage in normotensive and hypertensive subjects.
    Barnett AJ; Bobik A; Carson V; Korman JS; McLean AJ
    Clin Exp Pharmacol Physiol; 1977; 4(4):331-9. PubMed ID: 908178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.
    Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT
    Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of Visken to methyldopa therapy in hypertension: a multicentre study.
    Murphy JE
    J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
    Bergstrand RH; Vedin JA; Wilhelmsson CE; Berglund G
    Eur J Clin Pharmacol; 1976; 10(6):375-9. PubMed ID: 793848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the use of reserpine versus alpha-methyldopa for second step treatment of hypertension in the elderly.
    Applegate WB; Carper ER; Kahn SE; Westbrook L; Linton M; Baker MG; Runyan JW
    J Am Geriatr Soc; 1985 Feb; 33(2):109-15. PubMed ID: 3968365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.